Proleukin® therapy, given in the abdominal cavity, or Nolvadex®, a hormonal blocking pill, have also been tried to treat ovarian cancer as well as other combination therapies.
Read through this oncology ovarian cancer page to learn more about these various treatments.
The average duration of survival after a recurrence of ovarian cancer is about 12 to 18 months, according to Texas Oncology.
This means that building a strong support system to maintain the highest quality of life possible, along with attempting to prolong one’s life, become the main goals.
Below are some links to ovarian cancer support resources.
Michele is an R.N. freelance writer with a special interest in women’s health care and quality of care issues.
Edited by Jody Smith
1) Recurrent Ovarian Cancer. Texasonlcology.com. Retrieved September 18, 2016.
2) Olivia W. Foley, BS et al. Recurrent Epithelial Ovarian Cancer: An Update on Treatment. Review Article | April 15, 2013 | Oncology Journal, Gynecologic Cancers, Ovarian Cancer.
3) Why has the cancer come back? Target Ovarian Cancer.org.uk. Retrieved September 18, 2016.